Top Markets
Coin of the day
Rapid Therapeutic Science Laboratories, Inc. Rapid Therapeutic Science Laboratories, Inc.

Rapid Therapeutic Science Laboratories, Inc.

RTSL
Rank in Stocks #42555
Rapid Therapeutic Science Laboratories, Inc. (RTSL) is a biotechnology firm... Rapid Therapeutic Science Laboratories, Inc. (RTSL) is a biotechnology firm specializing in the aerosolized delivery of non-psychoactive cannabinoids directly into the bloodstream. This innovative approach is aimed at treating various conditions, including chronic pain, post-traumatic stress disorder (PTSD), insomnia, and aiding in surgery recovery, among other health issues. RTSL's product portfolio features pressurized meter dose inhalers (MDIs), designed to precisely dispense an aerosolized mist into the lungs, alongside sublingual oral spray devices. Furthermore, the company offers water-soluble cannabidiol (CBD) and cannabigerol (CBG) isolates under its "nhaler" brand. Established in 2013 and based in Dallas, Texas, the company adopted its current name, Rapid Therapeutic Science Laboratories, Inc., in January 2020, having previously operated as Holly Brothers Pictures, Inc. It was also formerly a subsidiary of Texas Mdi, Inc.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$883.00
Change (1 day)
0.00%
Change (1 year)
-96.67%
Country
US
Trade Rapid Therapeutic Science Laboratories, Inc. (RTSL)

Category

P/S ratio for Rapid Therapeutic Science Laboratories, Inc. (RTSL)
P/S ratio as of 2026 TTM: 0
According to Rapid Therapeutic Science Laboratories, Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Rapid Therapeutic Science Laboratories, Inc. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
3.95 -
US
4.83 -
US
2.78 -
IE
3.31 -
US
7.61 -
US